Everolimus (Standard) | MedChemExpress (MCE)

Everolimus (Standard) is the analytical standard of Everolimus. This product is intended for research and analytical applications. Everolimus (RAD001) is a Rapamycin (HY-10219) derivative and a potent, selective and orally active mTOR1 inhibitor. Everolimus binds to FKBP-12 to generate an immunosuppressive complex. Everolimus inhibits tumor cells proliferation and induces cell apoptosis and autophagy. Everolimus has potent immunosuppressive and anticancer activities[1][2].

Trivial name Everolimus (Standard)
Catalog Number HY-10218R
Alternative Name(s) RAD001 (Standard); SDZ-RAD (Standard)
Research Area Cancer
CAS# 159351-69-6
Purity ≥98.0%
SMILES O=C([C@@]1(O)[C@@H](CC[C@@H](C[C@@H](/C(C)=C/C=C/C=C/[C@H](C[C@@H](C)C([C@@H]([C@@H](/C(C)=C/[C@H]2C)O)OC)=O)C)OC)O1)C)C(N3CCCC[C@H]3C(O[C@@H](CC2=O)[C@@H](C[C@H]4C[C@H]([C@H](OCCO)CC4)OC)C)=O)=O
Size 1 mg
Supplier Page https://www.medchemexpress.com/everolimus-standard.html